TELES Informationstechnologien AG (TLIK) - Total Liabilities
Based on the latest financial reports, TELES Informationstechnologien AG (TLIK) has total liabilities worth €4.29 Million EUR (≈ $5.01 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore TELES Informationstechnologien AG (TLIK) equity growth momentum to track the company's year-over-year net asset growth rate.
TELES Informationstechnologien AG - Total Liabilities Trend (2003–2024)
This chart illustrates how TELES Informationstechnologien AG's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does TELES Informationstechnologien AG generate to measure how efficiently the company converts operating cash flow to free cash.
TELES Informationstechnologien AG Competitors by Total Liabilities
The table below lists competitors of TELES Informationstechnologien AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chimeric Therapeutics Ltd
AU:CHM
|
Australia | AU$8.96 Million |
|
Tanah Laut Tbk
JK:INDX
|
Indonesia | Rp21.99 Billion |
|
Trufin PLC
LSE:TRU
|
UK | GBX14.17 Million |
|
Rubico Inc. Common Stock
NASDAQ:RUBI
|
USA | $88.27 Million |
|
Montanaro UK Smaller Companies Investment Trust PLC
LSE:MTU
|
UK | GBX13.84 Million |
|
CanadaBis Capital Inc
V:CANB
|
Canada | CA$16.64 Million |
|
Reinhold Europe AB
WAR:RHD
|
Poland | zł2.15 Million |
|
GEMINA LABS LTD
F:8I7
|
Germany | €6.25 Million |
Liability Composition Analysis (2003–2024)
This chart breaks down TELES Informationstechnologien AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TELES Informationstechnologien AG stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | N/A | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TELES Informationstechnologien AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TELES Informationstechnologien AG (2003–2024)
The table below shows the annual total liabilities of TELES Informationstechnologien AG from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €4.17 Million ≈ $4.87 Million |
-75.37% |
| 2023-12-31 | €16.92 Million ≈ $19.78 Million |
+1108.03% |
| 2022-12-31 | €1.40 Million ≈ $1.64 Million |
+13.09% |
| 2021-12-31 | €1.24 Million ≈ $1.45 Million |
+6.46% |
| 2020-12-31 | €1.16 Million ≈ $1.36 Million |
-58.11% |
| 2019-12-31 | €2.78 Million ≈ $3.25 Million |
-74.53% |
| 2018-12-31 | €10.90 Million ≈ $12.75 Million |
-5.85% |
| 2017-12-31 | €11.58 Million ≈ $13.54 Million |
+2.04% |
| 2016-12-31 | €11.35 Million ≈ $13.27 Million |
-21.63% |
| 2015-12-31 | €14.48 Million ≈ $16.93 Million |
-2.41% |
| 2014-12-31 | €14.84 Million ≈ $17.35 Million |
+0.30% |
| 2013-12-31 | €14.80 Million ≈ $17.30 Million |
-17.95% |
| 2012-12-31 | €18.03 Million ≈ $21.08 Million |
+4.48% |
| 2011-12-31 | €17.26 Million ≈ $20.18 Million |
-13.61% |
| 2010-12-31 | €19.98 Million ≈ $23.35 Million |
+18.92% |
| 2009-12-31 | €16.80 Million ≈ $19.64 Million |
+35.46% |
| 2008-12-31 | €12.40 Million ≈ $14.50 Million |
-11.57% |
| 2007-12-31 | €14.02 Million ≈ $16.39 Million |
+51.42% |
| 2006-12-31 | €9.26 Million ≈ $10.83 Million |
-65.97% |
| 2005-12-31 | €27.21 Million ≈ $31.81 Million |
-54.74% |
| 2004-12-31 | €60.12 Million ≈ $70.29 Million |
+93.54% |
| 2003-12-31 | €31.07 Million ≈ $36.32 Million |
-- |
About TELES Informationstechnologien AG
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.